State Street Corporation (STT) 13D/13G Filings for Design Therapeutics, Inc. (DSGN)

State Street Corporation 13D and 13G filings for Design Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-01-23
10:34 am
Sale
2023-12-31 13G Design Therapeutics, Inc.
DSGN
STATE STREET CORP
STT
695,224
1.240%
-2,342,236decrease
(-77.11%)
Filing
2023-02-08
1:03 pm
Purchase
2022-12-31 13G Design Therapeutics, Inc.
DSGN
STATE STREET CORP
STT
3,037,460
5.430%
3,037,460increase
(New Position)
Filing